Zhuang SW - Search Results

1

Clinical Complete Response After Conversion Therapy for Unresectable Hepatocellular Carcinoma: Is Salvage Hepatectomy Necessary?

Wu JY, Wu JY, Liu DY, Li H, Zhuang SW, Li B, Zhou JY, Huang JY, Zhang ZB, Li SQ, Yan ML, Wang YD. Wu JY, et al. Among authors: zhuang sw. J Hepatocell Carcinoma. 2023 Dec 5;10:2161-2171. doi: 10.2147/JHC.S442341. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 38076640 Free PMC article.

2

The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors.

Zeng ZX, Wu JY, Wu JY, Li YN, Fu YK, Zhang ZB, Liu DY, Li H, Ou XY, Zhuang SW, Yan ML. Zeng ZX, et al. Among authors: zhuang sw. Hepatol Int. 2024 Apr;18(2):651-660. doi: 10.1007/s12072-023-10613-x. Epub 2023 Dec 1. Hepatol Int. 2024. PMID: 38040945

3

Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study.

Ou X, Wu J, Wu J, Fu Y, Zeng Z, Li S, Li Y, Liu D, Li H, Li B, Zhou J, Zhuang S, Cheng S, Zhang Z, Wang K, Qu S, Yan M. Ou X, et al. Cancer Res Treat. 2024 Oct;56(4):1207-1218. doi: 10.4143/crt.2023.1165. Epub 2024 Apr 30. Cancer Res Treat. 2024. PMID: 38697847 Free PMC article.

4

Reply to: "Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed".

Zeng ZX, Wu JY, Zhuang SW, Yan ML. Zeng ZX, et al. Among authors: zhuang sw. Hepatol Int. 2024 Oct;18(5):1589-1590. doi: 10.1007/s12072-024-10682-6. Epub 2024 Jul 8. Hepatol Int. 2024. PMID: 38976226 No abstract available.

5

Prognostic Value of Pathological Response for Patients with Unresectable Hepatocellular Carcinoma Undergoing Conversion Surgery.

Zeng ZX, Wu JY, Wu JY, Zhang ZB, Wang K, Zhuang SW, Li B, Zhou JY, Lin ZT, Li SQ, Li YN, Fu YK, Yan ML. Zeng ZX, et al. Among authors: zhuang sw. Liver Cancer. 2024 Jan 27;13(5):498-508. doi: 10.1159/000536376. eCollection 2024 Oct. Liver Cancer. 2024. PMID: 39435272 Free PMC article.

6

Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 Inhibitors.

Wei SM, Zeng ZX, Pan RJ, Wu JY, Wu JY, Luo MC, Li YN, Li H, Liu DY, Ou XY, Zhang ZB, Zhou JY, Li B, Zhuang SW, Yan ML. Wei SM, et al. Among authors: zhuang sw. J Inflamm Res. 2025 Jun 10;18:7545-7557. doi: 10.2147/JIR.S520339. eCollection 2025. J Inflamm Res. 2025. PMID: 40529897 Free PMC article.

7

Long-term survival in advanced unresectable HCC treated with transcatheter arterial chemoembolization combined with lenvatinib and PD-1 inhibitors.

Zeng ZX, Song HC, Li YN, Wu JY, Liang D, Li SQ, Zhang ZB, Zhuang SW, Li B, Zhou JY, Liu DY, Li H, Ou XY, Pan RJ, Wu JY, Yan ML. Zeng ZX, et al. Among authors: zhuang sw. Oncologist. 2025 Jun 4;30(6):oyaf058. doi: 10.1093/oncolo/oyaf058. Oncologist. 2025. PMID: 40549042 Free PMC article.

8

Effect of regorafenib combined with immunotherapy and arterial chemoembolization on the survival of patients with advanced hepatocellular carcinoma: a retrospective study.

Liu M, Zhuang S, Xu J, Zheng S. Liu M, et al. Am J Transl Res. 2025 Mar 15;17(3):1962-1973. doi: 10.62347/BXYO6569. eCollection 2025. Am J Transl Res. 2025. PMID: 40226031 Free PMC article.

9

Prognostic effects of different malignant obstructive jaundice sites on percutaneous biliary intervention: A retrospective controlled study.

Xu J, Zhuang S, Liu M, Wu S, Li H. Xu J, et al. J Cancer Res Ther. 2023 Feb;19(1):78-85. doi: 10.4103/jcrt.jcrt_2038_22. J Cancer Res Ther. 2023. PMID: 37006046 Free article.

10

[Percutaneous biliary stent combined with brachytherapy for malignant obstructive jaundice: a multicenter retrospective controlled study].

Huang XH, Wu SH, Li P, Ke Q, Weng XT, Li L, Liu DX, Zhuang SW, Sun JH, Guo WH. Huang XH, et al. Among authors: zhuang sw. Zhonghua Gan Zang Bing Za Zhi. 2022 Jul 20;30(7):702-709. doi: 10.3760/cma.j.cn501113-20220728-00399. Zhonghua Gan Zang Bing Za Zhi. 2022. PMID: 36038338 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters